India  
 
NewsR.in

China's Sinopharm says its Covid-19 vaccine is 79% effective

Video Credit: Bleacher Report AOL - Duration: 01:41s - Published
China's Sinopharm says its Covid-19 vaccine is 79% effective

China's Sinopharm says its Covid-19 vaccine is 79% effective

China’s state-owned pharmaceutical giant Sinopharm has announced its coronavirus vaccine is 79.34% effective.

Interim analysis of Phase 3 clinical trials show the vaccine is safe and people who received two doses produced high-level antibodies, according to a statement published by Beijing Biological Products Institute Co., a Sinopharm subsidiary.


You Might Like

Related news from verified sources

China's Sinopharm says vaccine '79% effective'

Phase 3 trials of a Sinopharm coronavirus vaccine in China have been found to be 79 percent...
IndiaTimes - Published


Related videos from verified sources

China gives conditional approval to vaccine [Video]

China gives conditional approval to vaccine

China approved a COVID-19 vaccine developed by an affiliate of state-backed pharmaceutical giant Sinopharm on Thursday, making it the country's first approved shot for general public use, as it braces..

Credit: Reuters Studio     Duration: 00:58Published
Covid: Is new virus variant more deadly? CSIR DG comments amid India alert [Video]

Covid: Is new virus variant more deadly? CSIR DG comments amid India alert

After the Government of India said that a new variant of the Sars-CoV-2 coronavirus discovered in the United Kingdom hasn't been found in India yet, director general of the Council of Scientific and..

Credit: HT Digital Content     Duration: 03:58Published
'Sanskrit richer than Greek, Latin': Kasturirangan on NEP language row #HTLS2020 [Video]

'Sanskrit richer than Greek, Latin': Kasturirangan on NEP language row #HTLS2020

Krishnaswamy Kasturirangan extolled the virtues of the multiple language push in the National Education Policy 2020. The former ISRO chief and chairman of the committee which drew up the draft..

Credit: HT Digital Content     Duration: 07:46Published